Kosan Biosciences Incorporated

Kosan BioSciences reports Q1 2006 revenues of $3 million, up from $2.9 million in 2005

Published in Medicine and Law Weekly, May 26th, 2006

Kosan Biosciences Incorporated (KOSN) reported revenues of $3 million for the quarter ended March 31, 2006, compared to $2.9 million in the same period in 2005.

Total operating expenses were $13.9 million for the quarter ended March 31, 2006, compared to $11.2 million in the same period last year.

Net losses for the quarter ended March 31, 2006 were $10.6 million, or 36 cents per share, compared to $8 million, or 28 cents per share, in the same period for the prior year. At March 31, 2006, cash, cash equivalents, restricted cash and marketable securities totaled $45.5 million (excluding net proceeds of approximately $23.9 million resulting from the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medicine and Law Weekly

Source: Medicine and Law Weekly (2006-05-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry